| Death | Death at home | ||
---|---|---|---|---|
Unadjusted HR (95% CI) | p-value | Unadjusted HR (95% CI) | p-value | |
Oxygen use | 0.59 (0.39–0.88) | 0.011 | 0.58 (0.36–0.92) | 0.021 |
Age | 0.99 (0.97–1.00) | 0.16 | 0.99 (0.98–1.01) | 0.50 |
Sex, male | 1.33 (0.93–1.91) | 0.12 | 1.25 (0.83–1.89) | 0.28 |
Systolic blood pressure | 0.99 (0.98–1.00) | 0.008 | 0.98 (0.97–0.99) | 0.002 |
Heart rate | 1.00 (0.99–1.01) | 0.94 | 1.01 (1.00–1.02) | 0.24 |
Oxygen saturation | 1.02 (0.98–1.06) | 0.28 | 1.02 (0.98–1.07) | 0.27 |
Decreased level of consciousness | 2.26 (1.57–3.24) | <  0.001 | 2.81 (1.86–4.24) | <  0.001 |
Dyspnea | 0.83 (0.57–1.20) | 0.32 | 0.98 (0.64–1.49) | 0.92 |
Edema | 1.09 (0.76–1.55) | 0.64 | 1.14 (0.76–1.71) | 0.51 |
Oral intake | 0.48 (0.36–0.62) | <  0.001 | 0.31 (0.22–0.43) | <  0.001 |
Performance status | 1.68 (1.29–2.18) | <  0.001 | 2.14 (1.59–2.87) | <  0.001 |
Cardiopulmonary comorbidity | 0.44 (0.25–0.80) | 0.006 | 0.46 (0.23–0.91) | 0.026 |
Lung cancer as primary tumor | 0.76 (0.51–1.14) | 0.18 | 0.73 (0.45–1.17) | 0.19 |